These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1035 related articles for article (PubMed ID: 23899558)

  • 1. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.
    Chen MB; Zhang Y; Wei MX; Shen W; Wu XY; Yao C; Lu PH
    Cell Signal; 2013 Oct; 25(10):1993-2002. PubMed ID: 23712032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
    Agarwal S; Bell CM; Rothbart SB; Moran RG
    J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
    Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent.
    Li C; Cui JF; Chen MB; Liu CY; Liu F; Zhang QD; Zou J; Lu PH
    Cancer Biol Ther; 2015; 16(1):34-42. PubMed ID: 25692620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
    Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X
    Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014.
    Huo HZ; Zhou ZY; Wang B; Qin J; Liu WY; Gu Y
    Biochem Biophys Res Commun; 2014 Jan; 443(2):406-12. PubMed ID: 24309100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
    Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
    Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy depletion of bovine mammary epithelial cells activates AMPK and suppresses protein synthesis through inhibition of mTORC1 signaling.
    Burgos SA; Kim JJ; Dai M; Cant JP
    Horm Metab Res; 2013 Mar; 45(3):183-9. PubMed ID: 22972179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
    Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis.
    Wang B; Wang XB; Chen LY; Huang L; Dong RZ
    Biochem Biophys Res Commun; 2013 Jul; 437(1):1-6. PubMed ID: 23743198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells.
    Kim YM; Hwang JT; Kwak DW; Lee YK; Park OJ
    Ann N Y Acad Sci; 2007 Jan; 1095():496-503. PubMed ID: 17404062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
    Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside.
    Rivas DA; Yaspelkis BB; Hawley JA; Lessard SJ
    J Endocrinol; 2009 Sep; 202(3):441-51. PubMed ID: 19574345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
    Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
    Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
    Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
    J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
    Zajkowicz A; Rusin M
    Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.
    Habib SL; Yadav A; Kidane D; Weiss RH; Liang S
    Cell Cycle; 2016 Nov; 15(22):3048-3059. PubMed ID: 27611085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.